Published Friday 20 September 2019 By Maria Cohut, Ph.D. Fact checked by Paula Field
An open-label clinical trial working with eight people with Alzheimer’s disease concluded that a new wearable device that emits electromagnetic impulses was able to significantly improve memory loss in seven of these participants within 2 months.
Scientists have been aware of this aspect of Alzheimer’s for years but have so far been unable to prevent the aggregates from forming, or to dissolve them once formed — not in humans, at least.
But now, researchers affiliated with NeuroEM Therapeutics — a medical device company based in Phoenix, AZ — have developed a wearable device that, according to their recent open-label clinical trial, can significantly reduce memory loss in Alzheimer’s by disaggregating toxic protein formed in the brain.
The device has the shape of a cap, and it emits electromagnetic waves in a frequency that, as preclinical studies in mice have shown, can help reverse memory loss. The research team that conducted the clinical trial reports the groundbreaking results in a study paper that appears in the Journal of Alzheimer’s Disease.
The original article where I found this news did not have an illustration, so I did a search.